204 related articles for article (PubMed ID: 35840847)
1. Inflammatory Breast Cancer: Is There a Role for Deescalation of Surgery?
Nakhlis F
Ann Surg Oncol; 2022 Oct; 29(10):6106-6113. PubMed ID: 35840847
[TBL] [Abstract][Full Text] [Related]
2. Current Surgical Management of Inflammatory Breast Cancer.
Adesoye T; Lucci A
Ann Surg Oncol; 2021 Oct; 28(10):5461-5467. PubMed ID: 34346020
[TBL] [Abstract][Full Text] [Related]
3. Contemporary surgical management of inflammatory breast cancer: a narrative review.
Adesoye T; Irwin S; Sun SX; Lucci A; Teshome M
Chin Clin Oncol; 2021 Dec; 10(6):57. PubMed ID: 35016511
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for locoregional failure in patients with inflammatory breast cancer treated with trimodality therapy.
Saigal K; Hurley J; Takita C; Reis IM; Zhao W; Rodgers SE; Wright JL
Clin Breast Cancer; 2013 Oct; 13(5):335-43. PubMed ID: 23850216
[TBL] [Abstract][Full Text] [Related]
5. Tailoring Treatment for Patients with Inflammatory Breast Cancer.
Newman AB; Lynce F
Curr Treat Options Oncol; 2023 Jun; 24(6):580-593. PubMed ID: 37043118
[TBL] [Abstract][Full Text] [Related]
6. Patterns of breast reconstruction in patients diagnosed with inflammatory breast cancer: The Dana-Farber Cancer Institute's Inflammatory Breast Cancer Program experience.
Nakhlis F; Regan MM; Chun YS; Dominici LS; Caterson S; Bellon JR; Warren L; Yeh ED; Jacene HA; King TA; Overmoyer B
Breast J; 2020 Mar; 26(3):384-390. PubMed ID: 31448540
[TBL] [Abstract][Full Text] [Related]
7. Extent of axillary surgery in inflammatory breast cancer: a survival analysis of 3500 patients.
Fayanju OM; Ren Y; Greenup RA; Plichta JK; Rosenberger LH; Force J; Suneja G; Devi GR; King TA; Nakhlis F; Hyslop T; Hwang ES
Breast Cancer Res Treat; 2020 Feb; 180(1):207-217. PubMed ID: 31960171
[TBL] [Abstract][Full Text] [Related]
8. Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer.
DeSnyder SM; Mittendorf EA; Le-Petross C; Krishnamurthy S; Whitman GJ; Ueno NT; Woodward WA; Kuerer HM; Akay CL; Babiera GV; Yang W; Lucci A
Clin Breast Cancer; 2018 Feb; 18(1):e73-e77. PubMed ID: 28755879
[TBL] [Abstract][Full Text] [Related]
9. The Prognostic Value of Axillary Staging Following Neoadjuvant Chemotherapy in Inflammatory Breast Cancer.
Grova MM; Strassle PD; Navajas EE; Gallagher KK; Ollila DW; Downs-Canner SM; Spanheimer PM
Ann Surg Oncol; 2021 Apr; 28(4):2182-2190. PubMed ID: 32974693
[TBL] [Abstract][Full Text] [Related]
10. Improved Locoregional Control in a Contemporary Cohort of Nonmetastatic Inflammatory Breast Cancer Patients Undergoing Surgery.
Rosso KJ; Tadros AB; Weiss A; Warneke CL; DeSnyder S; Kuerer H; Ueno NT; Stecklein SR; Woodward WA; Lucci A
Ann Surg Oncol; 2017 Oct; 24(10):2981-2988. PubMed ID: 28766220
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer.
Nakhlis F; Regan MM; Warren LE; Bellon JR; Hirshfield-Bartek J; Duggan MM; Dominici LS; Golshan M; Jacene HA; Yeh ED; Mullaney EE; Overmoyer B
Ann Surg Oncol; 2017 Sep; 24(9):2563-2569. PubMed ID: 28560598
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Radiation Therapy for Chemorefractory Localized Inflammatory Breast Cancer.
Rogé M; Kirova Y; Loap P; Amar S; Servagi S; Nebbache R; Rivin Del Campo E; Clatot F; Thureau S; Thariat J
Pract Radiat Oncol; 2023; 13(6):e491-e498. PubMed ID: 37295726
[TBL] [Abstract][Full Text] [Related]
13. Low Rates of Local-Regional Recurrence Among Inflammatory Breast Cancer Patients After Contemporary Trimodal Therapy.
Adesoye T; Everidge S; Chen J; Sun SX; Teshome M; Valero V; Woodward WA; Lucci A
Ann Surg Oncol; 2023 Oct; 30(10):6232-6240. PubMed ID: 37479842
[TBL] [Abstract][Full Text] [Related]
14. Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy?
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Dar AR; Venkatesan VM; Stitt L; Radwan JS
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):551-9. PubMed ID: 9231679
[TBL] [Abstract][Full Text] [Related]
15. Immediate Reconstruction in Inflammatory Breast Cancer: Challenging Current Care.
Simpson AB; McCray D; Wengler C; Crowe JP; Djohan R; Tendulkar R; O'Rourke C; Grobmyer SR; Valente SA
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):642-648. PubMed ID: 27638670
[TBL] [Abstract][Full Text] [Related]
16. Axillary Pathologic Complete Response in Inflammatory Breast Cancer Patients: Implications for SLNB?
Imeokparia FO; Hughes TM; Dossett LA; Jeruss JS; Chang AE; Sabel MS
Ann Surg Oncol; 2019 Oct; 26(10):3374-3379. PubMed ID: 31342381
[TBL] [Abstract][Full Text] [Related]
17. UNICANCER-PEGASE 07 study: a randomized phase III trial evaluating postoperative docetaxel-5FU regimen after neoadjuvant dose-intense chemotherapy for treatment of inflammatory breast cancer.
Gonçalves A; Pierga JY; Ferrero JM; Mouret-Reynier MA; Bachelot T; Delva R; Fabbro M; Lerebours F; Lotz JP; Linassier C; Dohollou N; Eymard JC; Leduc B; Lemonnier J; Martin AL; Boher JM; Viens P; Roché H
Ann Oncol; 2015 Aug; 26(8):1692-7. PubMed ID: 25943350
[TBL] [Abstract][Full Text] [Related]
18. Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes.
Hieken TJ; Murphy BL; Boughey JC; Degnim AC; Glazebrook KN; Hoskin TL
Clin Breast Cancer; 2018 Aug; 18(4):e501-e506. PubMed ID: 29089281
[TBL] [Abstract][Full Text] [Related]
19. Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) study.
Semiglazov V; Eiermann W; Zambetti M; Manikhas A; Bozhok A; Lluch A; Tjulandin S; Sabadell MD; Caballero A; Valagussa P; Baselga J; Gianni L
Eur J Surg Oncol; 2011 Oct; 37(10):856-63. PubMed ID: 21843921
[TBL] [Abstract][Full Text] [Related]
20. Long-term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement.
Cobb AN; Diao K; Teshome M; Lucci A; Ueno NT; Stauder M; Layman RM; Kuerer HM; Woodward WA; Sun SX
Ann Surg Oncol; 2022 Oct; 29(10):6381-6392. PubMed ID: 35834145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
